Francois-Xavier Frapaise, who led the privately held Asphelia Pharmaceuticals in its quest to treat patients using worms known as helminths for inflammatory conditions such as ulcerative colitis and Crohn's Disease, has accepted a position as chief scientific officer of Optimer Pharmaceuticals...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99